What are the opening hours?

Monday 9am - 5:30pm Tuesday 9am - 5:30pm Wednesday 9am - 5:30pm Thursday 9am - 5:30pm Friday 9am - 5:30pm

Cel-Sci Corporation

Home
United States
Vienna, VA
Cel-Sci Corporation

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cel-Sci Corporation, Medical Service, 8229 Boone Boulevard, Suite 802, Vienna, VA.

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.

02/18/2026

CEL-SCI is focused on two major value-driving milestones in the near term—starting enrollment in our U.S. FDA confirmatory Registration trial of Multikine in head and neck cancer and advancing Multikine globally in markets including Saudi Arabia.

CEL-SCI reported financial results for three months ended December 31, 2025, as well as key recent clinical and corporate developments.

12/29/2025

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Corporation reports financial results for the fiscal year ended September 30, 2025, as well as key clinical and corporate developments.

10/20/2025

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025. You can register to watch the virtual presentation at 9:30 a.m. PST by following this link: https://lnkd.in/g9ib3b4V.
https://www.newsfilecorp.com/release/270944

Vienna, Virginia--(Newsfile Corp. - October 20, 2025) - CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, previously...

10/10/2025

CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference

Vienna, Virginia--(Newsfile Corp. - October 10, 2025) - CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, today...

09/24/2025

Geert Kersten, CEO of CEL-SCI, discusses the innovative approach of using immunotherapy, specifically Multikine, in cancer treatment. He emphasizes the importance of the immune system in fighting cancer and the need for a paradigm shift in how cancer therapies are developed and administered.

In this episode of Drug Diaries, Geert Kersten, CEO of Cel-Sci, discusses the innovative approach of using immunotherapy, specifically Multikine, in cancer t...

08/13/2025

Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline

CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia.

07/11/2025

CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer

CEL-SCI to sign partnership agreement with leading Saudi Arabian pharma company for Multikine in the treatment of head & neck cancer.

06/18/2025

FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients

FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine.

05/21/2025

CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia

CEL-SCI’S Multikine investigational cancer medicine potentially available for commercialization by summer 2025 in Saudi Arabia.

05/15/2025

CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results

CEL-SCI reports fiscal second quarter 2025 financial results.

05/12/2025

Geert Kersten, CEO of CEL-SCI, was interviewed on Fox News:

Learn about the cutting-edge medical research happening at CEL-SCI—and how it’s changing the future of cancer immunotherapy.www.cel-sci.com

04/23/2025

CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia

CEL-SCI to file for Regulatory Approval of Multikine in Saudi Arabia—Pursuing local partnerships to serve Middle East and North Africa Market

Address

8229 Boone Boulevard, Suite 802
Vienna, VA
22182

Opening Hours

Monday	9am - 5:30pm
Tuesday	9am - 5:30pm
Wednesday	9am - 5:30pm
Thursday	9am - 5:30pm
Friday	9am - 5:30pm

Telephone

+17035069460

Website

http://www.cel-sci.com/

Alerts

Be the first to know and let us send you an email when Cel-Sci Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Vienna?